Myriad Genetics Announces Five Research Collaborations to Study the Use of MRD Testing in Breast Cancer
08 oct. 2024 16h05 HE
|
Myriad Genetics, Inc.
SALT LAKE CITY, Oct. 08, 2024 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today announced a series of ongoing research...
Myriad Genetics and Personalis Cross-License Foundational MRD Intellectual Property to Broaden Patient Access to Testing
11 juil. 2024 09h00 HE
|
Myriad Genetics, Inc.
SALT LAKE CITY and FREMONT, Calif., July 11, 2024 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (Nasdaq: MYGN), a leader in genetic testing and precision medicine, and Personalis, Inc. (Nasdaq: PSNL)...
Myriad Genetics Announces Second Foundational Patent Granted for Molecular Residual Disease (MRD) with Early Priority Date
09 juil. 2024 09h00 HE
|
Myriad Genetics, Inc.
SALT LAKE CITY, July 09, 2024 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today announced that the United States Patent and...
Global Minimal Residual Disease Testing Market Projected to Surpass US$ 5.1 Billion by 2032, Driven by Technological Advancements, & Clinical Applications and End-User Engagement
03 mai 2024 05h29 HE
|
Research and Markets
Dublin, May 03, 2024 (GLOBE NEWSWIRE) -- The "Minimal Residual Disease Testing Market by Technology, Application, End User, and Region 2024-2032" report has been added to ResearchAndMarkets.com's...
Global MRD Testing Market Projected to Reach $6.67 Billion by 2033, Driven by Advances in Cancer Detection Technology
19 mars 2024 12h23 HE
|
Research and Markets
Dublin, March 19, 2024 (GLOBE NEWSWIRE) -- The "MRD Testing Market - Global and Regional Analysis: Focus on Technology, Target Detection, End User and Region Analysis - Analysis and Forecast,...
Asia-Pacific Measurable/Minimal Residual Disease (MRD) Testing Market Analysis 2023-2033 - Medicare Expansion and Rising Consumer Awareness Driving Growth
08 mars 2024 09h33 HE
|
Research and Markets
Dublin, March 08, 2024 (GLOBE NEWSWIRE) -- The "Asia-Pacific MRD Testing Market: Analysis and Forecast, 2023-2033" report has been added to ResearchAndMarkets.com's offering.The Asia-Pacific MRD...
Europe MRD Testing Market Report 2024: Analysis and Forecasts 2023-2033 Featuring Cergentis , F. Hoffmann-La Roche, and ICON
06 févr. 2024 09h12 HE
|
Research and Markets
Dublin, Feb. 06, 2024 (GLOBE NEWSWIRE) -- The "Europe MRD Testing Market: Analysis and Forecast, 2023-2033" report has been added to ResearchAndMarkets.com's offering.The Europe MRD testing market...
Global Minimal Residual Disease Testing Market Report 2023-2028 Featuring Key Players - Adaptive Biotechnologies, Invitae, Guardant Health, Natera, NeoGenomics, Exact Sciences, and Quest Diagnostics
30 août 2023 04h43 HE
|
Research and Markets
Dublin, Aug. 30, 2023 (GLOBE NEWSWIRE) -- The "Minimal Residual Disease Testing: Global Markets and Technologies" report has been added to ResearchAndMarkets.com's offering. The global market for...
Minimal Residual Disease Testing Market to hit USD 4.1 billion by 2032, says Global Market Insights Inc.
14 août 2023 17h30 HE
|
Global Market Insights Inc.
Selbyville, Delaware, Aug. 14, 2023 (GLOBE NEWSWIRE) -- Minimal Residual Disease Testing Market size is expected to be worth USD 4.1 billion by 2032. The global minimal residual disease (MRD)...
Global MRD (Minimal Residual Disease) Testing Research Report 2023: Rising Number of Clinical Trials in Prolonged MRD-Negative Treatment Decisions Present Opportunities
21 juil. 2023 04h18 HE
|
Research and Markets
Dublin, July 21, 2023 (GLOBE NEWSWIRE) -- The "MRD Testing Market - Global and Regional Analysis: Focus on Technology, Target Detection, End User and Region Analysis - Analysis and Forecast,...